5 Strategies to Reduce Screen Failures in Trials

A research coordinator at a clinical trial site once spent half a day preparing for a screening visit. The study she was enrolling for was a trial of a prosthetic device, designed for people who had undergone an amputation. The patient walked in with all four limbs intact and a polite question about whether this was the study he had heard about on the radio. Both sides had been talking about two different studies the whole time. The afternoon ended with a screen failure on the books, even though the only thing that had actually failed was the conversation that should have happened before the visit.

Screen failures, the term clinical research sites use when a person comes in to be considered for a study but cannot be enrolled, happen for many reasons. Some of those reasons are about the science of the study. The person's blood test values fall outside the range the study allows, or their medical history rules them out, or a recent procedure they had makes them ineligible for safety reasons. These failures cannot be talked away. They belong to the protocol, which is the written plan that defines who a study is for and what happens during it. A site cannot widen who qualifies, and a coordinator cannot make a lab value something it is not.

The rest of the failures look different up close. They happen because something a person needed to know was not communicated clearly, something they could have prepared for was not explained, or something they were quietly worried about was not addressed. Those failures are not about the protocol. They are about how the site set up the experience around it. Sites that work at this layer of the problem consistently see lower screen failure rates than sites that focus only on the science layer.

The five practices below sit at that layer. None of them require sponsor approval or new technology, and they reward sustained attention more than one-time effort.

1. Tell people what the study is actually looking for, in plain language, before they come in

The amputation story is not unusual in the way it sounds. The details vary; the pattern is the same. A person hears about a study, decides it sounds like something that could help them or someone they care about, and arrives at the site assuming the study is for someone like them. The site assumes the patient already knows what the study is studying. Neither side has actually checked.

The fix is uncomfortably simple. Before the screening visit is scheduled, the site shares a short, plain-language description of who the study is for, what the condition is, and what someone has to have, or not have, to be considered. The description is in writing, in language a person without a medical background can read, and in the format the patient is most likely to actually look at, which is usually a text message or a short web page rather than a multi-page consent document.

The level of detail matters. A line that reads, "We are looking for people who have type 2 diabetes and are between 40 and 70 years old, who have not started a new diabetes medication in the last three months," works better than a copy-paste of the inclusion criteria from the protocol document. The first version is something a person can hold up against their own life and answer honestly. The second version is something a person nods through and then asks the coordinator to explain when they arrive.

Sites that build this small habit recover hours of coordinator time that used to be spent in visits that were never going to result in enrollment. The companion piece Pre-Screening Smarter: How Technology Reduces Screen Failures at Sites covers how technology can extend the same idea to a larger candidate pool.

2. Help patients prepare for the screening visit itself

A meaningful share of screen failures happen because a person showed up for the visit without knowing the small things that would have helped them. They skipped breakfast and arrived dehydrated. They forgot to mention the over-the-counter pain reliever they take twice a week. They left their list of supplements on the kitchen counter. They did not bring the cardiology report from the appointment they had two months ago.

None of these things are the patient's fault. They are the result of a site assuming the patient knows what kind of visit this is going to be. A medical appointment, in most people's experience, is something you show up to and answer questions about how you have been feeling. A screening visit for a clinical study is a different kind of appointment, and the practical preparation a person needs to do for it is different.

A short instructions document, sent the day before, changes the outcome. What to eat or not eat that morning. Whether to bring a list of every medication, including the ones the person does not consider serious. Whether to bring recent test results. Whether to bring a family member. How long the visit is likely to take. What the person can ask if something is unclear. These details look ordinary, and that is the point. The work of a screening visit goes better when both sides walked in knowing what was going to happen.

Borderline lab values are one of the most common reasons a person fails a screening they would otherwise have passed, and many of those values are sensitive to whether the person ate, drank, or slept well the night before. Reducing Screen Failures in Clinical Trials: How Sites Can Improve Eligibility Matching covers the wider eligibility-matching picture this practice plugs into.

3. Talk to the patient's regular doctor when there is one

Patients who arrive at a research site through a referral, from their primary care doctor, a specialist, or a hospital department, carry a story their referring doctor knows better than the site does. A recent change in medication. A test result that was not flagged as important at the time. A planned procedure scheduled for next month. A condition the patient does not bring up because they have lived with it for so long that it does not occur to them to mention.

A short conversation with the referring doctor before the visit catches a lot of this. The conversation does not need to be long. Five minutes by phone, or a brief secure message, asking the doctor to confirm the patient's current medications, recent diagnoses, and any pending procedures, is enough to surface most of the surprises that would otherwise turn up during the screening visit.

The conversation also strengthens a relationship that matters for the next patient. A referring doctor who sees that the site treated their patient thoughtfully, asked the right questions, and explained the result in a way the patient could understand, is more likely to refer the next person they think might be a fit. Sites that hold these conversations consistently build a referral network that screens better than any other source.

The wider posture around recruitment, including how sites position themselves to receive thoughtful referrals from the community, is the subject of The Recruitment Struggle Is Real: What Today's Sites Need to Compete.

4. Make it easy for someone who did not qualify the first time to try again later

Some people who do not qualify for a study on the day they come in would qualify later. The infection they were recovering from clears up. The medication they were on is something they finish. The lab value that fell just outside the window drifts back inside it. Six weeks or six months later, the same person, for the same study, is a strong fit.

Most sites lose these people. The visit ends, the failure is filed, and the patient goes home thinking the study was not for them. Nobody reaches back out, and the work that went into the original visit is written off.

Sites that handle this differently make two small changes. They note, at the time of the screen failure, why the person did not qualify and whether the reason is something that could change. They keep a quiet record of patients who might be candidates again later. When the situation changes, the site reaches back out directly and asks whether the person would like to be considered again. The conversation is short and respectful, and the conversion rate is high, because the patient already knows the site and trusts that the second invitation is honest.

The basic record-keeping that makes this possible is a function of a well-used Clinical Trial Management System, the software sites use to track their studies. Clinical Trial Management Systems: The Backbone of Site Operations covers how that infrastructure supports practices like this.

5. Listen to why people walk away, not just whether they fit

A portion of the patients counted as screen failures every month are not disqualified by the study. They withdraw. They consent, sit through part of the visit, and then decide they would rather not continue. The site records this as a screen failure, because that is the technical category, but the reason has nothing to do with the protocol.

Sometimes the patient felt rushed. Sometimes a phrase in the consent conversation worried them and nobody noticed. Sometimes they sensed that the coordinator was focused on the form rather than on the person sitting across the desk. Sometimes the patient came in already unsure and the visit did not give them a reason to feel sure. These are not protocol problems. They are visit-experience problems, and they are within the site's control.

Sites that ask people who step out why they did, and listen to the answer without trying to talk them back in, learn things about their own workflow that no enrollment report will surface. Maybe the consent conversation moves too fast. Maybe the room used for screening feels clinical in a way that makes people guarded. Maybe a coordinator's question about prior medications sounds like an accusation when the patient hears it. Each of these is fixable, and each one, fixed, keeps more of the next month's candidates through to enrollment.

Building the broader habits that support this kind of attention, including how a site team treats every person who walks through the door, is the subject of Site Management in Clinical Trials: 4 Proven Ways to Boost Efficiency.

How DecenTrialz supports site teams in reducing screen failures

DecenTrialz is a participant screening platform that connects people in the United States who may want to join a clinical study with the research teams running those studies. The platform uses AI-assisted participant matching against study eligibility criteria, registered nurse-led pre-screening conversations, and structured referral workflows to make sure candidates arrive at the site already understanding what the study is, what it is looking for, and what to expect.

The platform's work sits at the layer this article is about. A registered nurse completes the initial pre-screening conversation in plain language, walks the person through the practical preparation they will need to do, and refers candidates to the research site only after they have cleared the most failure-prone eligibility points. Final eligibility verification, the consent conversation, and enrollment remain with the study team at the research site, because those responsibilities sit with the investigator under United States clinical research regulations.

For site teams working on studies with strict eligibility windows or complex pre-visit logistics, the practical effect is that more of the people who arrive for screening visits already fit, already understand the study, and already know what they walked in for. Sites can see how that pipeline works at DecenTrialz.

Next steps for research sites

The five practices in this article do not require capital or sponsor permission. They are available to any site running studies today. Each one rewards the kind of sustained attention to small things that already separates the strongest research sites from the rest.

For site teams that want to see how a structured pre-screening conversation changes what arrives at the screening visit, you can begin at decentrialz.com.